TrialJournal of the International AIDS Society2022

Perspectives of people living with HIV-1 on implementation of long-acting cabotegravir plus rilpivirine in US healthcare settings: results from the CUSTOMIZE hybrid III implementation-effectiveness study.

Cindy P Garris et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.